Livingston, New Jersey Clinical Trials

A listing of Livingston, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
T3-S3-UK

Testing

Online studies
Accepts healthy volunteers
UK Site
(online study) Contact site
  • 0 views
  • 16 May, 2025
  • 1 location
  • Online study
UAT_Local 01-19-May  

This is for UAT_Local 01-19-May.

Online studies
Accepts healthy volunteers
UAT-UK
(online study)
  • 0 views
  • 19 May, 2025
  • 1 location
  • Online study
Test

In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary computed tomography angiography (CCTA) with NiFFR assessment. Patients were followed for one year to monitor for MACE

Online studies
  • 0 views
  • 28 Aug, 2025
  • Online study
Social & QoL Behaviors in Parkinson's Disease

Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same …

Online studies
Accepts healthy volunteers
  • 0 views
  • 02 Apr, 2026
  • Online study
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

ventricular septal defects
right heart catheterization
patent ductus arteriosus
HIV Infection
macitentan 10 mg
Morristown Medical Center
 (8.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +210 other locations
formal test 2

formal test 2formal test 2

Site 1
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (SURVIVE)

The primary purpose of this study is to determine whether adding SurVaxM to standard chemotherapy with temozolomide is better than treatment with temozolomide alone for patients with newly diagnosed glioblastoma. This study is designed to compare the duration of survival in patients with newly diagnosed glioblastoma receiving temozolomide plus SurVaxM …

Atlantic Health
 (5.7 away) Contact site
  • 0 views
  • 02 Dec, 2024
  • +9 other locations
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

This is a Phase 1/2, open-label, multiple-center, dose escalation and cohort expansion study to evaluate the safety and efficacy of NGGT002 in adult subjects with classic Phenylketonuria (PKU). NGGT002 is an rAAV8 based vector carrying a functional copy of the human PAH gene.Participants will receive a single administration of NGGT002 …

Atlantic Health System
 (8.1 away) Contact site
  • 0 views
  • 09 May, 2025
  • +1 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
alzheimer's disease
positron emission tomography
flortaucipir
mini-mental state examination
The Cognitive and Research Center of NJ
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
T1

tt

Site Test 1
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location